Microcefalia antes da chegada do vírus Zika: uma revisão do assunto
Barra lateral de artigos
Como Citar
Esta obra está licenciado com uma Licença Creative Commons Attribution 3.0 Unported License.
##plugins.themes.bootstrap3.displayStats.downloads##
Societal impact
Conteúdo do artigo principal
Resumo
Os relatórios de casos de microcefalia no Brasil há significado um desafio para a saúde pública, especialmente nos países da América Latina como a Colômbia, pois a pesar de sua suposta relação com o vírus Zika, se desconhece como os outros fatores implicados na etiologia da microcefalia se relacionam com este aumento de casos. Também se conta com poucas estadísticas epidemiológicas sobre o comportamento dos fatores etiológicos de microcefalia até o ano chave de 2015, não só no Brasil se não na maioria de países latino-americanos. As estimações da incidência e prevalência de microcefalia são variáveis devido a diferenças nas definições, padrões de seguimento e diferenças entre as populações que têm e as que não têm validados os padrões de diagnóstico e seguimentos de microcefalia. Se realiza uma revisão com uma olhada geral à microcefalia, se unificam definições, classificação e etiologia.
Detalhes do artigo
Referências
Organización Panamericana de la Salud. Lineamientos preliminares de vigilancia de microcefalia en recién nacidos en entornos de riesgo de circulación de virus Zika. Recuperado a partir de: http://www.paho.org/hq/index.php?option=com_docman&task=doc_ view&Itemid=270&gid=32999.
Brasil Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Protocolo de vigilância e resposta à ocorrência de microcefalia relacionada à infecção 16 pelo vírus Zika. Brasília: Ministério da Saúde, 2015.
Brasil Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Note Informativa 01/2015. COES 14 Microcefalias. Brasília: Ministério da Saúde, 2015.
Latin American Network of Congenital Malformations. Microcefalias en el ECLAMC y en Brasil. 2015. http://www.eclamc.org/ microcefaliaarchivos.php.
Almeida IM, Ramos CV, Rodrigues DC, Sousa AC, Nascimento ML, Silva MV, et al. Clinical and epidemiological aspects of microcephaly in the state of Piauí, northeastern Brazil, 2015-2016. J Pediatr (Rio J). 2018; 95(4):466-74.
Díaz-Menéndez M, Trigo E, De la Calle-Prieto F, Arsuaga M. Zika virus infection during the Olympic Games in Rio: A fear or an actual risk? Rev Clin Esp. 2017; 217(3):155-60.
Caylà JA, Domínguez Á, Rodríguez E, De Ory F, Vázquez A, Fortuny C. [Zika virus infection: A new public health emergency with great media impact]. Gac Sanit. 2016; 30(6):468-71.
Nunes ML, Carlini CR, Marinowic D, Neto FK, Fiori HH, Scotta MC, et al. Microcephaly and Zika virus: A clinical and epidemiological analysis of the current outbreak in Brazil. J Pediatr (Rio J). 2016; 92(3):230-40.
Mlakar J, Korva M, Tul N, Popovic M, Poljˇsak-Prijatelj M, Mraz J, et al. Zika virus associated with microcephaly. N Engl J Med. 2016; 374:951-8.
Martínez P, Suy A, Sánchez-Montalvá A, Rodó C, Salvador F, MolinaI. Zika fever. Enferm Infecc Microbiol Clin. 2016; 34(4):247-52.
Boom JA. Microcephaly in infants and children: Etiology and evaluation. [Internet]. 2016. Recuperado a partir de: http://www.uptodate.com.consultaremota.upb.edu.co/contents/ microcephaly-in-infants-and-children-etiology-and-evaluation?source=search_result&searc h=microcephaly&selectedTitle=1%7E135.
Chenel C, Wood C, Gourrier E, Zittoun J, Casadevall I, Ogier H. [Neonatal haemolytic–uraemic syndrome, methylmalonic aciduria and homocystinuria caused by intracellular vitamin B 12 deficiency. Value of aetiological diagnosis]. Arch Fr Pediatr. 1993; 50:749-54.
Victora CG, Schuler-Faccini L, Matijasevich A, Ribeiro E, Pessoa A, Barros FC. Microcephaly in Brazil: How to interpret reported numbers? Lancet. 2016; 387(10019):621-4.
Daymont C, Hwang W-T, Feudtner C, Rubin D. Head-circumference distribution in a large primary care network differs from CDC and WHO curves. Pediatrics. 2010; 126(4):e836-42.
Stoll C. Problems in the diagnosis of fragile X syndrome in young children are still present. Am J Med Genet. 2001; 100(2):110-5.
Zvulunov A, Weitz R, Metzker A. Neurofibromatosis type 1 in childhood: Evaluation of clinical and epidemiologic features as predictive factors for severity. Clin Pediatr (Phila). 1998; 37(5):295-9.
Furuta T, Tabuchi A, Adachi Y, Mizumatsu S, Tamesa N, Ichikawa T, et al. Primary brain tumors in children under age 3 years. Brain Tumor Pathol. 1998; 15(1):7-12.
Tomita T, McLone DG. Brain tumors during the first twenty-four months of life. Neurosurgery. 1985; 17(6):913-9.
Gleeson JG, Dobyns WB, Plawner L, Ashwal S. Congenital structural defects. In: Pediatric Neurology Principles and Practice, 4th ed, Swaiman KF, Ashwal S, Ferriero DM (Eds), Mosby Elsevier, Philadelphia 2006. p.399.
Abuelo D. Microcephaly syndromes. Semin Pediatr Neurol. 2007; 14(3):118-27.
Leroy JG, Frías JL. Nonsyndromic microcephaly: An overview. Adv Pediatr. 2005; 52:261-93.
Roche AF, Mukherjee D, Guo SM, Moore WM. Head circumference reference data: Birth to 18 years. Pediatrics. 1987; 79(5):706-12.
Ashwal S, Michelson D, Plawner L, Dobyns WB. Practice parameter: Evaluation of the child with microcephaly (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2009; 73(11):887-97.
Menkes JH, Sarnat HB, Flores-Sarnat L. Malformations of the central nervous system. In: Child Neurology, 7th ed, Menkes JH, Sarnat HB, Maria BL (Eds), Lippincott Williams & Wilkins, Philadelphia 2006. p.284.
WHO. The WHO Child Growth Standards [Internet]. 2016. Recuperado a partir de: http://www. who.int/childgrowth/en/
Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013; 13(59):10.1186/1471-2431-13-59.
Villar J, Cheikh L, Victora CG. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet 2014; 384:857–68.
Gibbons L, Belizan JM, Lauer JA, Betran AP, Merialdi M, Althabe F. Inequities in the use of cesarean section deliveries in the world. Am J Obstet Gynecol 2012; 206:e1-19.
Giuliani F, Ohuma E, Spada E. Systematic review of the methodological quality of studies designed to create neonatal anthropometric charts. Acta Paediatr 2015; 104:987–96.
WHO. Birth defects surveillance: A manual for programme managers. Geneva: World Health Organization, 2014.
Hamill PV, Drizd TA, Johnson CL, Reed RB, Roche AF. NCHS growth curves for children birth-18 years. United States. Vital Health Stat. 1977; (165):1-74.
Kuczmarski RJ, Ogden CL, Guo SS. 2000 CDC growth charts for the United States: Methods and development. Vital Health Stat. 2002; (246):1-190.
WHO, Multicentre Growth Reference Study Group. WHO child growth standards: Head circumference for age, arm circumference for age, triceps skinfold for age and subscapular skinfold for age — Methods and Development. Geneva, Switzerland; 2007.
Rollins JD, Collins JS, Holden KR. United States head circumference growth reference charts: Birth to 21 years. J Pediatr. 2010; 156(6):907-13.
Grummer-Strawn LM, Reinold C, Krebs NF, Centers for Disease Control and Prevention (CDC). Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States. MMWR Recomm Rep Morb Mortal. 2010; 59(RR-9):1-15.
Wright CM, Inskip HM, Godfrey K, Williams AF, Ong KK. Monitoring head size and growth using the new UK-WHO growth standard. Arch Dis Child. 2011; 96(4):386-8.
Natale V, Rajagopalan A. Worldwide variation in human growth and the World Health Organization growth standards: A systematic review. BMJ Open. 2014; 4(1):e003735.
Nellhaus G. Head circumference from birth to eighteen years. Practical composite international and interracial graphs. Pediatrics. 1968; 41(1):106-14.
Woods CG. Human microcephaly. Curr Opin Neurobiol. 2004; 14(1):112-7.
Von der Hagen M, Pivarcsi M, Liebe J. Diagnostic approach to microcephaly in childhood: A two-center study and review of the literature. Dev Med Child Neurol 2014; 56:732.
Abuelo D. Microcephaly syndromes. Semin Pediatr Neurol. 2007; 14:118–27.
Baxter PS, Rigby AS, Rotsaert MH, Wright I. Acquired microcephaly: Causes, patterns, motor and IQ effects, and associated growth changes. Pediatrics. 2009; 124:590–5.
Bartram JL, Rigby AS, Baxter PS. The “Lassoo” tape: stretch ability and observer variability in head circumference measurement. Arch Dis Child. 2005; 90(8):820- 21.
Bolduc FV, Shevell MI. Corrected head circumference centiles as a possible predictor of developmental performance in high-risk neonatal intensive care unit survivors. Dev Med Child Neurol. 2005; 47(11):766-77.
Nard JA. Abnormal head size and shape. In: Common & Chronic Symptoms in Pediatrics, Gartner JC, Zitelli BJ (Eds), Mosby, St. Louis 1997.
Coronado R, Giraldo J, Macaya A, Roig M. Head circumference growth function as a marker of neurological impairment in a cohort of microcephalic infants and children. Neuropediatrics. 2012; 43:271-4.
Holmes LB, Harvey EA, Coull BA. The teratogenicity of anticonvulsant drugs. N Engl J Med. 2001; 344:1132.
Dansky LV, Andermann E, Rosenblatt D, Sherwin AL, Andermann F. Anticonvulsants, folate levels, and pregnancy outcome: A prospective study. Ann Neurol. 1987; 21:176-82.
Holmes LD, Adams J, Coull B, Harvey EA. Anticonvulsant face: Association with cognitive dysfunction. Pediatric Res 2000; 47: Suppl:82A.
Wells PG, Winn LM. Biochemical toxicology of chemical teratogenesis. Clin Rev Biochem Mol Biol. 1996; 31:1-40.